TrialESMO open2026

Concordance between clinician-reported toxicities and patient-reported symptom severity in early-stage breast cancer: an analysis of the randomized phase III PANTHER trial.

P Filis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.